Model of colonic inflammation: Immune modulatory mechanisms in inflammatory bowel disease

Journal of Theoretical Biology

Volumn 264, Issue 4, 2010, Pages 1225-1239

  Wendelsdorf, Katherine ^a   Bassaganya Riera, Josep ^a   Hontecillas, Raquel ^a   Eubank, Stephen ^a  

^a VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

Gut immunity; Immune regulation; Immune tolerance; Mathematical model

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

BACTERIUM; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; NUMERICAL MODEL; PATHOGEN; PATHOLOGY;

ANTIGEN PRESENTING CELL; ARTICLE; COLON MUCOSA; DENDRITIC CELL; DIARRHEA; ENTERITIS; EPITHELIUM CELL; GENE MUTATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; INTESTINE FLORA; LAMINA PROPRIA; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MACROPHAGE; MALNUTRITION; MATHEMATICAL MODEL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SIMULATION; T LYMPHOCYTE;

COLON; DENDRITIC CELLS; EPITHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MACROPHAGES; MODELS, BIOLOGICAL; PPAR GAMMA; T-LYMPHOCYTES;

EID: 77952954251     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.03.027     Document Type: Article

References (59)

1. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8(6):411-420.
2. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 1996, 184(2):387-396.
3. Asseman C., Mauze S., Leach M.W., Coffman R.L., Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 1999, 190(7):995-1004.
4. Barba G., Rebouissoux L., Le Bail B., Lamireau T. [Recurrent pancreatitis revealing Crohn's disease]. Arch. Pediatr. 2002, 9(10):1053-1055.
5. Bassaganya-Riera J., Reynolds K., Martino-Catt S., Cui Y., Hennighausen L., Gonzalez F., Rohrer J., Benninghoff A.U., Hontecillas R. Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 2004, 127(3):777-791.
6. Bauer A., Beauchemin C.P.A. Agent-based modeling in host-pathogen systems: the successes and challenges. Inf. Sci. 2009, 179:1379-1389.
7. Blaser M.J., Kirschner D. Dynamics of helicobacter pylori colonization in relation to the host response. Proc. Nat. Acad. Sci. USA 1999, 96(15):8359-8364.
8. Braverman I.M. Skin signs of gastrointestinal disease. Gastroenterology 2003, 124(6):1595-1614.
9. Catron D.M., Itano A.A., Pape K.A., Mueller D.L., Jenkins M.K. Visualizing the first 50h of the primary immune response to a soluble antigen. Immunity 2004, 21(3):341-347.
10. Cho J.H. The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 2008, 8(6):458-466.
11. Clerc M., Kennedy J. The particle swarm-explosion, stability, and convergence in a multidimensional complex space. IEEE Trans. Evol. Comput. 2002, 6(1):58-73.
12. Day J., Friedman A., Schlesinger L.S. Modeling the immune rheostat of macrophages in the lung in response to infection. Proc. Nat. Acad. Sci. USA 2009, 106(27):11246-11251.
13. Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev.. 1999, 20(5):649-688.
14. Dubuquoy L., Jansson E.A., Deeb S., Rakotobe S., Karoui M., Colombel J.F., Auwerx J., Pettersson S., Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003, 124(5):1265-1276.
15. Geginat J., Lanzavecchia A., Sallusto F. Proliferation and differentiation potential of human cd8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood 2003, 101(11):4260-4266.
16. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5(12):953-964.
17. Haase A.T. Population biology of HIV-1 infection: viral and cd4(+) T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 1999, 17:625-656.
18. Hogue I.B., Bajaria S.H., Fallert B.A., Qin S., Reinhart T.A., Kirschner D.E. The dual role of dendritic cells in the immune response to human immunodeficiency virus type 1 infection. J. Gen. Virol. 2008, 89(Pt 9):2228-2239.
19. Hontecillas R., Bassaganya-Riera J. Peroxisome proliferator-activated receptor gamma is required for regulatory cd4+ T cell-mediated protection against colitis. J. Immunol. 2007, 178(5):2940-2949.
20. Hontecillas R., Bassaganya-Riera J., Wilson J., Hutto D.L., Wannemuehler M.J. Cd4+ T-cell responses and distribution at the colonic mucosa during brachyspira hyodysenteriae-induced colitis in pigs. Immunology 2005, 115(1):127-135.
21. Hoops S., Sahle S., Gauges R., Lee C., Pahle J., Simus N., Singhal M., Xu L., Mendes P., Kummer U. Copasi-a complex pathway simulator. Bioinformatics 2006, 22(24):3067-3074.
22. Iwasaki A. Mucosal dendritic cells. Annu. Rev. Immunol. 2007, 25:381-418.
23. Janeway C., Travers P., Walport M., Shlomchik M. Immunobiology: The Immune System in Health and Disease 2001, Garland Publishing, New York, NY. Fifth ed.
24. Jonasson R., Andersson M., Rasback T., Johannisson A., Jensen-Waern M. Immunological alterations during the clinical and recovery phases of experimental swine dysentery. J. Med. Microbiol. 2006, 55(Pt 7):845-855.
25. Junt T., Moseman E.A., Iannacone M., Massberg S., Lang P.A., Boes M., Fink K., Henrickson S.E., Shayakhmetov D.M., Di Paolo N.C., van Rooijen N., Mempel T.R., Whelan S.P., von Andrian U.H. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 2007, 450(7166):110-114.
26. Kamath A.T., Henri S., Battye F., Tough D.F., Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002, 100(5):1734-1741.
27. Katayama K., Wada K., Nakajima A., Mizuguchi H., Hayakawa T., Nakagawa S., Kadowaki T., Nagai R., Kamisaki Y., Blumberg R.S., Mayumi T. A novel ppar gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 2003, 124(5):1315-1324.
28. Kelly D., Campbell J.I., King T.P., Grant G., Jansson E.A., Coutts A.G., Pettersson S., Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 2004, 5(1):104-112.
29. Lang R., Rutschman R.L., Greaves D.R., Murray P.J. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing il-10 under control of the human cd68 promoter. J. Immunol. 2002, 168(7):3402-3411.
30. Lanzavecchia A., Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001, 106(3):263-266.
31. Lytle C., Tod T.J., Vo K.T., Lee J.W., Atkinson R.D., Straus D.S. The peroxisome proliferator-activated receptor gamma ligand rosiglitazone delays the onset of inflammatory bowel disease in mice with interleukin 10 deficiency. Inflamm. Bowel Dis. 2005, 11(3):231-243.
32. Mansen A., Guardiola-Diaz H., Rafter J., Branting C., Gustafsson J.A. Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Biochem. Biophys. Res. Commun. 1996, 222(3):844-851.
33. Marzo A.L., Klonowski K.D., Le Bon A., Borrow P., Tough D.F., Lefrancois L. Initial T cell frequency dictates memory cd8+ T cell lineage commitment. Nat. Immunol. 2005, 6(8):793-799.
34. Mohr E., Serre K., Manz R., Cunningham A., Khan M., Hardie D., Bird R., MacLennan C. Dendritic cells and monocyte/macropahges that create the il-6/april-rich lymph node microenvironments where plasmabasts mature. J. Immunol. 2009, 182:2113-2123.
35. Mokdad A.H., Ford E.S., Bowman B.A., Nelson D.E., Engelgau M.M., Vinicor F., Marks J.S. The continuing increase of diabetes in the US. Diabetes Care 2001, 24(2):412.
36. Nesto R.W., Bell D., Bonow R.O., Fonseca V., Grundy S.M., Horton E.S., Le Winter M., Porte D., Semenkovich C.F., Smith S., Young L.H., Kahn R. Thiazolidinedione use fluid retention and congestive heart failure: a consensus statement from the american heart association and american diabetes association. Circulation 2003, 108(23):2941-2948.
37. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A. Macrophage-specific ppargamma controls alternative activation and improves insulin resistance. Nature 2007, 447(7148):1116-1120.
38. Odegaard J.I., Ricardo-Gonzalez R.R., Red Eagle A., Vats D., Morel C.R., Goforth M.H., Subramanian V., Mukundan L., Ferrante A.W., Chawla A. Alternative M2 activation of kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 2008, 7(6):496-507.
39. Onishi Y., Fehervari Z., Yamaguchi T., Sakaguchi S. Foxp3(+) natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Nat. Acad. Sci. USA 2008, 105(29):10113-10118.
40. Ott S.J., Musfeldt M., Wenderoth D.F., Hampe J., Brant O., Folsch U.R., Timmis K.N., Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004, 53(5):685-693.
41. Powrie F., Leach M.W., Mauze S., Caddle L.B., Coffman R.L. Phenotypically distinct subsets of cd4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 1993, 5(11):1461-1471.
42. Reder C. Metabolic control theory: a structural approach. J. Theor. Biol. 1988, 135(2):175-201.
43. Riley J.L., June C.H., Blazar B.R. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009, 30(5):656-665.
44. Rutgeerts P., Vermeire S., Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009, 136(4):1182-1197.
45. Sallusto F., Geginat J., Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 2004, 22:745-763.
46. Shevach E.M. Cd4+ cd25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2002, 2(6):389-400.
47. Spiegelman B.M. PPARgamma in monocytes: less pain any gain?. Cell 1998, 93(2):153-155.
48. Stenson W.F. Interleukin-4 hyporesponsiveness in inflammatory bowel disease: immune defect or physiological response?. Gastroenterology 1995, 108(1):284-286.
49. Strober W., Fuss I.J., Blumberg R.S. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 2002, 20:495-549.
50. Sugawara K., Olson T.S., Moskaluk C.A., Stevens B.K., Hoang S., Kozaiwa K., Cominelli F., Ley K.F., McDuffie M. Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn's disease. Gastroenterology 2005, 128(2):351-360.
51. Swerdlin N., Cohen I.R., Harel D. The lymph node B cell immune response: dynamic analysis in-silico. Proc. IEEE 2008, 96(8):1421-1443.
52. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., Weber J., Hoffmann U., Schreiber S., Dietel M., Lochs H. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122(1):44-54.
53. Uhlig H.H., Coombes J., Mottet C., Izcue A., Thompson C., Fanger A., Tannapfel A., Fontenot J.D., Ramsdell F., Powrie F. Characterization of Foxp3(+)CD4(+)CD25(+) and IL-10-secreting CD4(+)CD25(+) T cells during cure of colitis. J. Immunol. 2006, 177(9):5852-5860.
54. von Andrian U.H., Mempel T.R. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 2003, 3(11):867-878.
55. Walker L.S., Chodos A., Eggena M., Dooms H., Abbas A.K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 2003, 198(2):249-258.
56. Wigginton J.E., Kirschner D. A model to predict cell-mediated immune regulatory mechanisms during human infection with mycobacterium tuberculosis. J. Immunol. 2001, 166(3):1951-1967.
57. Wohlfert E.A., Nichols F.C., Nevius E., Clark R.B. Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms. J. Immunol. 2007, 178(7):4129-4135.
58. Yang R., Han X., Uchiyama T., Watkins S.K., Yaguchi A., Delude R.L., Fink M.P. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285(3). G621-9.
59. Yona S., Gordon S. Inflammation: glucocorticoids turn the monocyte switch. Immunol. Cell Biol. 2007, 85(2):81-82.